Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Covalon Technologies Ltd (TSE:COV)
:COV
Earnings Data
Report Date
Jun 02, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.01Last Year’s EPS
0.06Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 21, 2025
|% Change Since: -11.95%
|Next Earnings Date:Jun 02, 2025
Earnings Call Sentiment|Positive
The earnings call showcased strong financial performance with record revenue growth and significant EBITDA improvement, alongside strategic recognitions and patent advancements. However, there were challenges including a sequential revenue decline and issues with the Seattle facility sublease. The overall sentiment remains optimistic with expectations of continued growth and strategic advancements.Company Guidance
In Covalon's Q1 Fiscal 2025 conference call, the company reported a strong financial performance with year-on-year revenue growth of 75%, reaching over $8 million, marking four consecutive quarters exceeding $7 million in revenue. Adjusted EBITDA increased to $1.5 million, a $2.9 million improvement from the previous year, and the trailing 12-month adjusted EBITDA was $7.8 million, which is nearly $12 million more than the preceding 12 months. The gross margin was consistent at 61.2%, and operating expenses were $3.7 million, reflecting a decrease from the prior year due to previous restructuring efforts. Covalon achieved an EPS of $0.04 per share, continuing its trend of positive earnings. The company ended the quarter with a strong cash position of $17.5 million and zero debt. Notably, the U.S. Medical Consumables business reported $7 million in revenue, a 74% increase from the previous year, supported by growth in both the U.S. Advanced Wound Care and the U.S. Vascular Access and Surgical business segments. The company also highlighted strategic achievements, including being named a TSX Ventures Exchange Top 50 Company and securing system-wide approval for its VALGuard product in a major U.S. health network.Record Revenue Growth
Reported fourth consecutive quarter of strong year-on-year growth with over $8 million in revenue, marking a 75% growth over the previous year.
Significant EBITDA Improvement
Adjusted EBITDA growth of $1.5 million, a $2.9 million improvement over the previous year, with trailing 12 months EBITDA at $7.8 million, almost $12 million more than the preceding 12 months.
Strategic Recognitions
Named as both a TSX Ventures Exchange Top 50 Company and an OTCQX Best 50 Company, recognizing outstanding performance in 2024.
New Patent Acceptance
U.S. Patent and Trade Office accepted Covalon's latest patent application for the VALGuard product, expected to be published in the next two to three months.
System-wide Approval for VALGuard
Secured system-wide approval for VALGuard use at one of the largest Integrated Delivery Networks in the U.S., potentially enabling deeper penetration.
Substantial Cash Position
Ended the quarter with $17.5 million in cash, more than double from a year ago, with zero debt.
---
TSE:COV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:COV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 21, 2025 | C$3.18 | C$2.80 | -11.95% |
| Jan 07, 2025 | C$3.59 | C$3.29 | -8.36% |
| Aug 21, 2024 | C$2.76 | C$3.00 | +8.70% |
| May 29, 2024 | C$1.11 | C$1.72 | +54.95% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Covalon Technologies Ltd (TSE:COV) report earnings?
Covalon Technologies Ltd (TSE:COV) is schdueled to report earning on Jun 02, 2025, TBA Not Confirmed.
What is Covalon Technologies Ltd (TSE:COV) earnings time?
Covalon Technologies Ltd (TSE:COV) earnings time is at Jun 02, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:COV EPS forecast?
TSE:COV EPS forecast for the fiscal quarter 2025 (Q2) is 0.01.
---